Vaccine jab could prevent heart attacks

Vaccine tested on mice found to direct body to lower cholesterol

A vaccine jab that prevents heart attacks could be on the cards after promising early research showing how the immune system can be directed to lower cholesterol.

Patients have already been enrolled into a Phase I trial to see if the approach, so far tested on mice, will work in humans.

In future, a cholesterol-lowering vaccine could theoretically provide a more effective and reliable alternative to statin drugs.

The vaccine, known as AT04A, triggers the production of antibodies that target an enzyme involved in regulating levels of blood cholesterol.

The enzyme, PCSK9, has been shown to impede the clearance of low-density lipoprotein — the “bad” form of cholesterol that is largely to blame for blocked arteries — from the blood.

In tests, mice fed an unhealthy Western-style fatty diet had their total blood cholesterol lowered by 53% by the vaccine.

Atherosclerotic damage, the build-up of hard fibrous deposits on the walls of arteries, was reduced by 64% and biological markers of blood vessel inflammation by up to 28% compared with unvaccinated mice.

The new results, published in the European Heart Journal, open up the prospect of a yearly vaccine jab to keep cholesterol under control in at-risk patients.

Researcher Dr Gunther Staffler, chief technology officer at the Austrian biotech company AFFiRis, which developed the vaccine, said: “AT04A was able to induce antibodies that specifically targeted the enzyme PCSK9 throughout the study period in the circulation of the treated mice. As a consequence, levels of cholesterol were reduced in a consistent and long-lasting way, resulting in a reduction of fatty deposits in the arteries and atherosclerotic damage, as well as reduced arterial wall inflammation.

“If these findings translate successfully into humans, this could mean that, as the induced antibodies persist for months after a vaccination, we could develop a long-lasting therapy that, after the first vaccination, just needs an annual booster. This would result in an effective and more convenient treatment for patients, as well as higher patient compliance.”

PCSK9 is made in the liver and blocks LDL receptor molecules on cells that allow the body to get rid of harmful cholesterol.

The vaccine causes the body to produce antibodies that lock onto and immobilise the enzyme, so that the LDL receptors can remain active.

Essentially, it is an immunotherapy treatment. Unlike a conventional vaccine that targets foreign invaders such as bacteria and viruses, AT04A marshals the immune system to attack one of the body’s own proteins.

A Phase I trial testing the safety and activity of the vaccine in 72 healthy patients was launched at the Medical University of Vienna in 2015. The trial is due to finish at the end of this year.

However, before the vaccine can be licensed and rolled out to patients, larger scale trials focusing on effectiveness as well as safety will have to be carried out.

British cardiovascular expert Dr Tim Chico, based at the University of Sheffield, said: “If similar effects were achieved in humans it would be likely to lead to a reduction in heart attacks.

“Many questions remain about whether this approach could work in man. The theory is sound and I think this might have the potential to replace the need to take regular cholesterol-lowering drugs.”


Lifestyle

Sating the festive appetite is what Christmas is all about, here Joe McNamee takes us through the best culinary delights that are produced right here on our doorstep.Want to give local this Christmas? Joe McNamee rounds up the the country's very best food produce

Architect and artist Harry Wallace tells Eve Kelliher how his style has evolved.How a lifetime as an architect has inspired Cork artist Harry Wallace

Don’t let present stress ruin your run-up to Christmas. Pat Fitzpatrick has done all the hard work with this tongue-in-cheek gift guide for every budget, so you can tick everyone off your list and get down to enjoying yourself for the festive season.Gift stressbuster: We sort out who gets what and why

It’s not what you have that makes you happy, it’s what you do. And what better time to be proactive than during the season of goodwill, says Margaret Jennings.Joy to the world: Strategies to increase your happiness during the season of goodwill

More From The Irish Examiner